Skip to main content
SpringerLink
Log in

The Adrenal Incidentaloma

  • Chapter
  • First Online:
Evidence-Based Endocrine Surgery

  • 602 Accesses

Abstract

Adrenal incidentaloma is very common and increasingly recognised due to the increasing number of high-quality scans or investigations amongst the general population. The challenge facing the endocrine multidisciplinary team is to sift out the minority of patients who require treatment, either for hyperfunctioning or very rarely for malignant disease.

This chapter provides guidance about investigation and treatment of incidentaloma on the basis of current available evidence. Uncertainty remains regarding size criteria for resection and follow-up protocols for those conservatively managed or under surveillance. In such cases individualised patient decision-making becomes increasingly more relevant.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Menegaux F, Chereau N, Peix J, Christou N, Lifante J, Paladino N, et al. Management of adrenal incidentaloma. J Visc Surg. 2014;151(5):355–64.

    Article  CAS  Google Scholar 

  2. Berland L, Silverman S, Gore R, Mayo-Smith W, Megibow A, Yee J, et al. Managing incidental findings on abdominal CT: White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol. 2010;7:754–73.

    Article  Google Scholar 

  3. Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2016;175(2):G1–G34.

    Article  CAS  Google Scholar 

  4. Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol. 2003;149:273–85.

    Article  CAS  Google Scholar 

  5. Grumbach M, Biller B, Braunstein G, Campbell K, Carney J, et al. Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med. 2003;138(5):424–9.

    Article  Google Scholar 

  6. Arnaldi G, Boscaro M. Adrenal incidentaloma. Best Pract Res Clin Endocrinol Metab. 2012;26(4):405–19.

    Article  CAS  Google Scholar 

  7. Kaltsas G, Chrisoulidou A, Piaditis G, Kassi E, Chrousos G. Current status and controversies in adrenal incidentalomas. Trends Endocrinol Metab. 2012;23(12):602–9.

    Article  CAS  Google Scholar 

  8. Kloos R, Gross M, Francis I, Korobkin M, Shapiro B. Incidentally discovered adrenal masses. Endocr Rev. 1995;16(4):460–84.

    CAS  PubMed  Google Scholar 

  9. Herrera M, Grant C, van Heerden J, Sheedy P, Ilstrup D. Incidentally discovered adrenal tumours: an institutional perspective. Surgery. 1991;110:1014–21.

    CAS  PubMed  Google Scholar 

  10. Zeiger M, Thompson B, Duh Q, Hamrahian A, Angelos P, Elaraj D, et al. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract. 2009;15(Suppl 1):S1–20.

    Article  Google Scholar 

  11. Bertherat J, Mosnier-Pudar H, Bertagna X. Adrenal incidentalomas. Curr Opin Oncol. 2002;14(1):58–63.

    Article  Google Scholar 

  12. Dinnes J, Bancos I, di Ruffano L, Chortis V, Davenport C, et al. Imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis. Eur J Endocrinol. 2016;175:R51–64.

    Article  CAS  Google Scholar 

  13. Song J, Chaudhry F, Mayo-Smith W. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol. 2008;190(5):1163–8.

    Article  Google Scholar 

  14. Kim J, Bae K, Choi Y, Jeong J, Park K, Kim J, et al. Clinical characteristics for 348 patients with adrenal incidentaloma. Endocrinol Metab. 2013;28:20–5.

    Article  Google Scholar 

  15. Ross N, Aron D. Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Engl J Med. 1990;323(20):1401–5.

    Article  CAS  Google Scholar 

  16. Minnaar E, Human K, Henneman D, Nio C, Bisschop P, Nieveen J e a. An adrenal Incidentaloma: how often is it detected and what are the consequences? ISRN Radiol. 2013;2013:1.

    Article  Google Scholar 

  17. Thompson G, Jn YW. Adrenal incidentaloma. Curr Opin Oncol. 2003;15(1):84–90.

    Article  Google Scholar 

  18. Funder J, Carey R, Fardella C, Gomez-Sanchez C, Mantero F, Stowasser M, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93:3266–81.

    Article  CAS  Google Scholar 

  19. Kumar S, Karthikeyan V, Manohar C, Sreelakshmi K, Shivalingaiah M. Adrenal schwannoma: a rare incidentaloma. J Clin Diag Res. 2016;10(8):PD01–2.

    Google Scholar 

  20. Khan I, Adlan M, Stechman M, Premawardhana L. A retroperitoneal leiomyosarcoma presenting as an adrenal incidentaloma in a subject on warfarin. Case Rep Endocrinol. 2015;2015:830814.

    PubMed  PubMed Central  Google Scholar 

  21. Lombardi C, Raffaelli M, Boniardi M, De Toma G, Marzano L, Miccoli P, et al. Adrenocortical carcinoma: effect of hospital volume on patient outcome. Langenbeck’s Arch Surg. 2012;397(2):201–7.

    Article  Google Scholar 

  22. F. Palazzo, A. Dickinson, B. Phillips, A. Sahdev, R. Bliss and A. Rasheed, et al. Adrenal surgery practice guidance for the UK 2016. 2016 [Online]. www.baets.org.uk/wp-content/uploads/Adrenal-Surgery-Practice-Guidance-for-the-UK-2016.pdf. Accessed 29 Jan 2017.

  23. National Institutes of Health. NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“incidentaloma”). NIH Consens State Sci Statements. 2002;19(2):1–25.

    Google Scholar 

  24. Lenders J, Duh Q, Eisenhofer G, Gimenez-Roqueplo A, Grebe S, et al. Pheochromocytoma and paraganglioma: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2014;99(6):1915–42.

    Article  CAS  Google Scholar 

  25. Di Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, Giampalma E, et al. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing’s syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol. 2014;2(5):396–405.

    Article  Google Scholar 

  26. Morelli V, Reimondo G, Giordano R, Della Casa S, Policola C, Palmieri S, et al. Long-term follow-up in adrenal incidentalomas: an Italian multicentre study. J Clin Endocrinol Metab. 2014;99(3):827–34.

    Article  CAS  Google Scholar 

  27. Giordano R, Marinazzo E, Berardelli R, Picu A, Maccario M, et al. Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas. Eur J Endocrinol. 2010;162:779–85.

    Article  CAS  Google Scholar 

  28. Debono M, Bradburn M, Bull M, Harrison B, Ross R, Newell-Price J. Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas. J Clin Endocrinol Metab. 2014;99(12):4462–70.

    Article  CAS  Google Scholar 

  29. Boland G, Blake M, Hahn P, Mayo-Smith W. Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology. 2008;249(3):756–75.

    Article  Google Scholar 

  30. Boland G, Lee M, Gazelle G, Halpern E, McNicholas M, Mueller P. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. Am J Roentgenol. 1998;171:201–4.

    Article  CAS  Google Scholar 

  31. Wale D, Wong K, Viglianti B, Rubello D, Gross M. Contemporary imaging of incidentally discovered adrenal masses. Biomed Pharmacother. 2017;87:256–62.

    Article  Google Scholar 

  32. Young W Jr. Conventional imaging in adrenocortical carcinoma: update and perspectives. Horm Cancer. 2011;2(6):341–7.

    Article  Google Scholar 

  33. Bharwani N, Rockall A, Sahdev A, Gueorguiev M, Drake W, et al. Adrenocortical carcinoma: the range of appearances on CT and MRI. AJR Am J Roentgenol. 2011;196:W706–14.

    Article  Google Scholar 

  34. Birsen O, Akyuz M, Dural C, Aksoy E, Aliyev S, Mitchell J, et al. A new risk stratification algorithm for the management of patients with adrenal incidentalomas. Surgery. 2014;156(4):959–65.

    Article  Google Scholar 

  35. Foo E, Turner R, Wang K, Aniss A, Gill A, Sidhu S, et al. Predicting malignancy in adrenal incidentaloma and evaluation of a novel risk stratification algorithm. ANZ J Surg. 2018;88(3):E173–7.

    Article  Google Scholar 

  36. Frilling A, Tecklenborg K, Weber F, Kuhl H, Muller S, Stamatis G, et al. Importance of adrenal incidentaloma in patients with a history of malignancy. Surgery. 2004;136(6):1289–96.

    Article  Google Scholar 

  37. Boland G, Dwamena B, Jagtiani Sangwaiya M, Goehler A, Blake M, Hahn P, et al. Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology. 2011;259(1):117–26.

    Article  Google Scholar 

  38. Caoili E, Korobkin M, Francis I, Cohan R, Platt J, Dunnick N, et al. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology. 2002;222(3):629–33.

    Article  Google Scholar 

  39. Kunikowska J, Matyskiel R, Toutounchi S, Grabowska-Derlatka L, Koperski L, Krolicki L. What parameters from 18F-FDG PET/CT are useful in evaluation of adrenal lesions? Eur J Nucl Med Mol Imaging. 2014;41:2273–80.

    Article  CAS  Google Scholar 

  40. Hahner S, Kreissl M, Fassnacht M, Haenscheid H, Bock S, et al. Functional characterization of adrenal lesions using [123I]IMTO-SPECT/CT. J Clin Endocrinol Metab. 2013;98(4):1508–18.

    Article  CAS  Google Scholar 

  41. Nieman L. Approach to the patient with an adrenal Incidentaloma. J Clin Endocrinol Metab. 2010;95(9):4106–13.

    Article  CAS  Google Scholar 

  42. Williams A, Hammer G, Else T. Transcutaneous biopsy of adrenocortical carcinoma is rarely helpful in diagnosis, potentially harmful, but does not affect patient outcome. Eur J Endocrinol. 2014;170(6):829–35.

    Article  CAS  Google Scholar 

  43. Lenert J, Barnett C Jr, Kudelka A, Sellin R, Gagel R, Prieto V, et al. Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy. Surgery. 2001;130(6):1060–7.

    Article  CAS  Google Scholar 

  44. Bancos I, Tamhane S, Shah M, Delivanis D, Alahdab F, Arlt W, et al. The diagnostic performance of adrenal biopsy: a systematic review and meta-analysis. Eur J Endocrinol. 2016;175:R65–80.

    Article  CAS  Google Scholar 

  45. Ye Y, Yuan X, Chen M, Dai Y, Qin Z, Zheng F. Management of adrenal incidentaloma: the role of adrenalectomy may be underestimated. BMC Surg. 2016;16:41.

    Article  Google Scholar 

  46. Terzolo M, Ali A, Osella G, Mazza E. Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici. Arch Surg. 1997;132(8):914–9.

    Article  CAS  Google Scholar 

  47. Bermini G, Miccoli P, Moretti A, Vivaldi M, Iacconi P, Salvetti A. Sixty adrenal masses of large dimentions: hormonal and morphologic evaluation. Urology. 1998;51(6):920–5.

    Article  Google Scholar 

  48. Kebebew E, Reiff E, Duh Q, Clark O, McMillan A. Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J Surg. 2006;30(5):872–8.

    Article  Google Scholar 

  49. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini A, Ali A. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab. 2000;85(2):637–44.

    CAS  PubMed  Google Scholar 

  50. Morelli V, Scillitani A, Arosio M, Chiodini I. Follow-up of patients with adrenal incidentaloma, in accordance with the European society of endocrinology guidelines: could we be safe? J Endocrinol Investig. 2017;40(3):331–3.

    Article  CAS  Google Scholar 

  51. Schalin-Jantti C, Raade M, Hamalainen E, Sane T. A 5-year prospective follow-up study of lipid-rich adrenal Incidentalomas: no tumor growth or development of hormonal hypersecretion. Endocrinol Metab. 2015;30:481–7.

    Article  CAS  Google Scholar 

  52. Muth A, Hammarstedt L, Hellstrom M, Sigurjonsdottir H, Almqvist E, Wangberg B, et al. Cohort study of patients with adrenal lesions discovered incidentally. Br J Surg. 2011;98(10):1383–91.

    Article  CAS  Google Scholar 

  53. Toniato A, Merante-Boschin I, Opocher G, Pelizzo M, Schiavi F, Ballotta E. Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study. Ann Surg. 2009;249(3):388–91.

    Article  Google Scholar 

  54. Tsuiki M, Tanabe A, Takagi S, Naruse M, Takano K. Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing’s syndrome. Endocr J. 2008;55(4):737–45.

    Article  CAS  Google Scholar 

  55. Iacobone M, Citton M, Viel G, Boetto R, Bonadio I, Mondi I. Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing's syndrome. Surgery. 2012;152(6):991–7.

    Article  Google Scholar 

  56. Donatini G, Caiazzo R, Do Cao C, Aubert S, Zerrweck C, El-Kathib Z, et al. Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach. Ann Surg Oncol. 2014;21(1):284–91.

    Article  Google Scholar 

  57. Mir M, Klink J, Guillotreau J, Long J, Miocinovic R, Kaouk J, et al. Comparative outcomes of laparoscopic and open adrenalectomy for adrenocortical carcinoma: single, high-volume Centre experience. Ann Surg Oncol. 2013;20(5):1456–61.

    Article  Google Scholar 

  58. Miller B, Ammori J, Gauger P, Broome J, Hammer G, Doherty G. Laparoscopic resection is inappropriate in patients with known or suspected adrenocortical carcinoma. World J Surg. 2010;34(6):1380–5.

    Article  CAS  Google Scholar 

  59. Miller B, Gauger P, Hammer G, Doherty G. Resection of adrenocortical carcinoma is less complete and local recurrence occurs sooner and more often after laparoscopic adrenalectomy than after open adrenalectomy. Surgery. 2012;152(6):1150–7.

    Article  Google Scholar 

  60. Reibetanz J, Jurowich C, Erdodan I, Nies C, Rayes N, Dralle H, et al. Impact of lymphadenectomy on the oncological outcome of patients with adrenocortical carcinoma. Ann Surg. 2012;255(2):263–9.

    Article  Google Scholar 

  61. Cooper A, Habra M, Grubbs E, Bednarski B, Ying A, Perrier N. Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma? Surg Endosc. 2013;27(11):4026–32.

    Article  Google Scholar 

  62. Castinetti F, Taieb D, Henry J, Walz M, Guerin C, Brue T. Outcome of adrenal sparing surgery in heritable pheochromocytoma. Eur J Endocrinol. 2016;174(1):R9–18.

    Article  CAS  Google Scholar 

  63. Nieman L. Update on subclinical Cushing’s syndrome. Curr Opin Endocrinol Diabetes Obes. 2015;22(3):180–4.

    Article  CAS  Google Scholar 

  64. Terzolo M, Bovio S, Pia A, Conton P, Reimondo G e a. Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma. Eur J Endocrinol. 2005;153:307–15.

    Article  CAS  Google Scholar 

  65. Chiodini I, Viti R, Coletti F, Guglielmi G, Battista C e a. Eugonadal male patients with adrenal incidentalomas and subclinical hypercortisolism have increased rate of vertebral fractures. Clin Endocrinol. 2009;70(2):208–13.

    Article  CAS  Google Scholar 

  66. Eller-Vainicher C, Morelli V, Ulivieri F, Palmieri S, Zhukouskaya V. Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with or without subclinical hypercortisolism. J Bone Miner Res. 2012;27(10):2223–30.

    Article  CAS  Google Scholar 

  67. Bulow B, Jansson SJC, Steen L, Thoren M, Wahrenberg H, et al. Adrenal incidentaloma- follow-up results from a Swedish prospective study. Eur J Endocrinol. 2006;154(3):419–23.

    Article  CAS  Google Scholar 

  68. Cawood THP, O’Shea D, Cole D, Soule S. Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer similar to the risk of the adrenal lesion becoming malignant; time for a rethink? Eur J Endocrinol. 2009;161:513–27.

    Article  CAS  Google Scholar 

  69. Libe R, Dall'Asta C, Barbetta L, Baccarelli A, Beck-Peccoz P, Ambrosi B. Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol. 2002;147(4):489–94.

    Article  CAS  Google Scholar 

  70. Muth A, Taft C, Hammarstedt L, Bjorneld L, Hellstrom M, WAngberg B. Patient-reported impacts of a conservative management programme for the clinically inapparent adrenal mass. Endocrine. 2013;44(1):228–36.

    Article  CAS  Google Scholar 

  71. Davenport E, Lang Ping Nam P, Wilson M, Reid A, Aspinall S. Adrenal incidentalomas: management in British district general hospitals. Postgrad Med J. 2014;90(1065):365–9.

    Article  Google Scholar 

  72. Sahni P, Trivedi A, Omer A, Trivedi N. Adrenal incidentalomas: are they being worked up appropriately? J Community Hosp Intern Med Perspect. 2016;6:32913.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrine Surgery, University Hospital of Wales, Cardiff, UK

    Richard Egan & David Scott-Coombes

Authors
  1. Richard Egan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Scott-Coombes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Scott-Coombes .

Editor information

Editors and Affiliations

  1. Division of Endocrine Surgery, National University Hospital, Singapore, Singapore

    Rajeev Parameswaran

  2. Department of Endocrine Surgery, SGPGI Hospital, Lucknow, India

    Amit Agarwal

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media Singapore

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Egan, R., Scott-Coombes, D. (2018). The Adrenal Incidentaloma. In: Parameswaran, R., Agarwal, A. (eds) Evidence-Based Endocrine Surgery. Springer, Singapore. https://doi.org/10.1007/978-981-10-1124-5_25

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-1124-5_25

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-1123-8

  • Online ISBN: 978-981-10-1124-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation